查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600191

產後出血治療設備市場：按產品、可用性、分銷管道、應用 - 全球預測 2025-2030

Postpartum Hemorrhage Treatment Devices Market by Product, Usability, Distribution Channel, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年產後出血治療器材市值為81,289萬美元，預計2024年將達到8,6094萬美元，複合年成長率為6.25%，預計到2030年將達到124295萬美元。

產後出血 (PPH) 治療設備是用於管理和控制產後出血過多的重要醫療工具，產後出血是全球孕產婦死亡的主要原因。這些醫療設備的需求源於需要透過提供快速有效的干涉措施來確保孕產婦安全並降低死亡率。這些設備包括球囊填塞、非氣動抗休克服、先進凝血劑等，主要應用於醫院及產科診所等醫療機構。這些設備的最終用途主要涉及產科醫生、婦科醫生和其他專注於最佳化孕產婦保健標準的孕產婦保健專業人員。

主要市場統計
基準年[2023] 81289萬美元
預測年份 [2024] 86094萬美元
預測年份 [2030] 12.4295億美元
複合年成長率（%） 6.25%

該市場的主要成長要素是已開發地區和新興地區對孕產婦健康的認知和重視程度的提高，以及醫療設備技術的進步。此外，醫療保健支出的增加以及政府改善孕產婦護理措施的支持也有助於市場擴張。潛在的商機包括開發具有成本效益的攜帶式設備，這在資源有限的環境中尤其重要。公司還可以利用數位技術進行設備使用培訓和教育，從而提高醫護人員的採用率。

限制市場成長的挑戰包括先進設備的高成本、低收入地區的使用機會有限以及缺乏接受過使用這些設備培訓的熟練醫療保健人員。監管障礙也對新參與企業和創新構成重大障礙。為了克服這些限制，創新可以集中於開發經濟可行且方便用戶使用的設備，這些設備整合了易於使用和監控的智慧技術。進一步的研究還可以探索解決產科護理多個方面的多功能設備的開發。市場仍在蓬勃發展，許多公司正在投資研發以提高設備的效率和安全性。相關人員應注重策略合作，以促進全球分銷網路和培訓計劃，並確保 PPH 治療設備的廣泛採用和接受。

市場動態：快速發展的產後出血治療設備市場的關鍵市場洞察

供需的動態交互作用正在改變產後出血治療設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 妊娠併發症增加，如子宮倒置和多胎妊娠
    • 產後出血發生率高
    • 旨在延續醫療改革和改善孕產婦醫療服務的舉措
  • 市場限制因素
    • 產後出血治療設備高成本
  • 市場機會
    • 技術進步與新型PPH治療設備的推出
    • 針對產後出血等的真空引血控制裝置的問世
  • 市場挑戰
    • 缺乏訓練有素的醫療保健提供者

波特五力：駕馭產後出血治療設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解產後出血治療設備市場的外部影響

外部宏觀環境因素在塑造產後出血治療設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解產後出血治療器材市場競爭狀況

產後出血治療設備市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣產後出血治療設備市場供應商的績效評估

FPNV定位矩陣是評估產後出血治療設備市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃產後出血治療設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對產後出血治療設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 妊娠併發症增加，例如子宮倒轉和多胎妊娠
      • 產後出血發生率高
      • 持續推動醫療改革和改善婦幼保健服務的舉措
    • 抑制因素
      • 產後出血治療設備費用高
    • 機會
      • 技術進步與新型PPH治療設備的推出
      • 介紹用於產後出血等的吸引式止血裝置。
    • 任務
      • 缺乏訓練有素的醫護人員
  • 市場區隔分析
    • 產品：使用非氣動衝擊服作為即時和臨時措施的顯著好處
    • 分銷管道：優先考慮能快速獲得產品的線下分銷管道
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章產後出血治療設備市場：依產品

  • 非氣動衝擊服
  • 預填充注射系統
  • 子宮填塞裝置
    • 球囊填塞
    • Foley導管

第7章產後出血治療設備市場：依可用性

  • 免洗裝置
  • 可重複使用的裝置

第8章產後出血治療器材市場：依分銷管道分類

  • 離線
  • 線上

第9章產後出血治療器材市場：依應用分類

  • 診所
  • 醫院

第10章北美及南美產後出血治療器材市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太產後出血治療器材市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東、非洲產後出血治療器材市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Laborie Medical Technologies Corp. 收購 Urotronic, Inc. 以加強介入性泌尿系統產品組合
    • Medtrade 和 Kebomed Europe AG 聯手加強整個歐洲的產後出血護理
  • 戰略分析和建議

公司名單

  • 3RD Stone Design, Inc.
  • Bactiguard Holding AB
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Cook Medical, Inc.
  • GE HealthCare Technologies, Inc.
  • Laborie Medical Technologies, Inc.
  • Merck & Co., Inc.
  • Organon & Co.
  • Procurenet Limited
  • Ribbel International Limited
  • Sinapi Biomedical
  • Teleflex, Inc.
  • Utah Medical Products Inc.
Product Code: MRR-DD5AD9F59CCA

The Postpartum Hemorrhage Treatment Devices Market was valued at USD 812.89 million in 2023, expected to reach USD 860.94 million in 2024, and is projected to grow at a CAGR of 6.25%, to USD 1,242.95 million by 2030.

Postpartum hemorrhage (PPH) treatment devices are essential medical tools designed to manage and control excessive bleeding following childbirth, a leading cause of maternal mortality globally. The necessity for these devices stems from the need to ensure maternal safety and reduce mortality rates by providing rapid and effective interventions. These devices, which include balloon tamponade, non-pneumatic anti-shock garments, and advanced blood clotting agents, are employed primarily in healthcare facilities such as hospitals and maternity clinics. The end-use of these devices predominantly involves obstetricians, gynecologists, and other maternity care professionals focused on optimizing maternal healthcare standards.

KEY MARKET STATISTICS
Base Year [2023] USD 812.89 million
Estimated Year [2024] USD 860.94 million
Forecast Year [2030] USD 1,242.95 million
CAGR (%) 6.25%

A key growth factor in this market is the increasing awareness and emphasis on maternal health in both developed and developing regions, alongside technological advancements in medical devices. Additionally, a rise in healthcare expenditures and support from government initiatives to improve maternal care contribute to market expansion. Potential opportunities include the development of cost-effective and portable devices, particularly crucial for resource-limited settings. Companies can also leverage digital technology for training and education on device usage, enhancing adoption rates among healthcare workers.

Challenges limiting market growth include the high cost of advanced devices, limited access in low-income regions, and a deficit of skilled healthcare professionals trained in the usage of such equipment. Regulatory hurdles also pose a significant barrier to entry for new players and innovations. To overcome these limitations, innovation could focus on creating economically viable, user-friendly devices that integrate smart technology for ease of use and monitoring. Further research could explore the development of multifunctional devices that address multiple aspects of obstetric care. The market remains dynamic, with numerous players investing in R&D to enhance device efficiency and safety. Stakeholders should focus on strategic collaborations to foster global distribution networks and training programs, ensuring the widespread implementation and acceptance of PPH treatment devices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Postpartum Hemorrhage Treatment Devices Market

The Postpartum Hemorrhage Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in complications in pregnancy, such as inverted uterus and multiple pregnancies
    • High prevalence of postpartum hemorrhage
    • Ongoing healthcare reforms and initiatives aimed at improving maternal health services
  • Market Restraints
    • High cost of postpartum hemorrhage treatment devices
  • Market Opportunities
    • Technological advancements and launch of new PPH treatment devices
    • Emergence of vacuum-induced hemorrhage control device for postpartum hemorrhage and others
  • Market Challenges
    • Scarcity of trained healthcare providers

Porter's Five Forces: A Strategic Tool for Navigating the Postpartum Hemorrhage Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Postpartum Hemorrhage Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Postpartum Hemorrhage Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Postpartum Hemorrhage Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Postpartum Hemorrhage Treatment Devices Market

A detailed market share analysis in the Postpartum Hemorrhage Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Postpartum Hemorrhage Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Postpartum Hemorrhage Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Postpartum Hemorrhage Treatment Devices Market

A strategic analysis of the Postpartum Hemorrhage Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Postpartum Hemorrhage Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include 3RD Stone Design, Inc., Bactiguard Holding AB, Becton, Dickinson and Company, Cardinal Health, Inc., Cook Medical, Inc., GE HealthCare Technologies, Inc., Laborie Medical Technologies, Inc., Merck & Co., Inc., Organon & Co., Procurenet Limited, Ribbel International Limited, Sinapi Biomedical, Teleflex, Inc., and Utah Medical Products Inc..

Market Segmentation & Coverage

This research report categorizes the Postpartum Hemorrhage Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Non-Pneumatic Anti-Shock Garment, Prefilled Injection System, and Uterine Tamponade Devices. The Uterine Tamponade Devices is further studied across Balloon Tamponade and Foley Catheter.
  • Based on Usability, market is studied across Disposable Devices and Reusable Devices.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Application, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in complications in pregnancy, such as inverted uterus and multiple pregnancies
      • 5.1.1.2. High prevalence of postpartum hemorrhage
      • 5.1.1.3. Ongoing healthcare reforms and initiatives aimed at improving maternal health services
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of postpartum hemorrhage treatment devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and launch of new PPH treatment devices
      • 5.1.3.2. Emergence of vacuum-induced hemorrhage control device for postpartum hemorrhage and others
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of trained healthcare providers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant benefits of non-pneumatic anti-shock garments as an immediate and temporary measure
    • 5.2.2. Distribution Channel: Higher preferences for offline distribution channels for quick product accessibility
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Postpartum Hemorrhage Treatment Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Non-Pneumatic Anti-Shock Garment
  • 6.3. Prefilled Injection System
  • 6.4. Uterine Tamponade Devices
    • 6.4.1. Balloon Tamponade
    • 6.4.2. Foley Catheter

7. Postpartum Hemorrhage Treatment Devices Market, by Usability

  • 7.1. Introduction
  • 7.2. Disposable Devices
  • 7.3. Reusable Devices

8. Postpartum Hemorrhage Treatment Devices Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Postpartum Hemorrhage Treatment Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Hospitals

10. Americas Postpartum Hemorrhage Treatment Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Postpartum Hemorrhage Treatment Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Postpartum Hemorrhage Treatment Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Laborie Medical Technologies Corp. Acquires Urotronic, Inc. to Enhance Interventional Urology Portfolio
    • 13.3.2. Medtrade and Kebomed Europe AG Join Forces to Enhance Postpartum Hemorrhage Care Across Europe
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3RD Stone Design, Inc.
  • 2. Bactiguard Holding AB
  • 3. Becton, Dickinson and Company
  • 4. Cardinal Health, Inc.
  • 5. Cook Medical, Inc.
  • 6. GE HealthCare Technologies, Inc.
  • 7. Laborie Medical Technologies, Inc.
  • 8. Merck & Co., Inc.
  • 9. Organon & Co.
  • 10. Procurenet Limited
  • 11. Ribbel International Limited
  • 12. Sinapi Biomedical
  • 13. Teleflex, Inc.
  • 14. Utah Medical Products Inc.

LIST OF FIGURES

  • FIGURE 1. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY NON-PNEUMATIC ANTI-SHOCK GARMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFILLED INJECTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BALLOON TAMPONADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY FOLEY CATHETER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISPOSABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REUSABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE TAMPONADE DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023